Status:
COMPLETED
Glutathione (GSH) In The Treatment of Parkinson's Disease
Lead Sponsor:
University of South Florida
Collaborating Sponsors:
Wellness Health & Pharmaceuticals, Inc.
Conditions:
Parkinson's Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This is an investigator initiated pilot study to examine the effects of GSH in PD. The goal of this study is to acquire some basic data regarding side effects and efficacy of this compound to determin...
Detailed Description
Inclusion Criteria Idiopathic Parkinson's disease (2 of 3 of the cardinal symptoms, tremor, bradykinesia, rigidity) Mini Mental State Examination \> 24 Anti-parkinsonian medications stable for one mon...
Eligibility Criteria
Inclusion
- Idiopathic Parkinson's disease (2 of 3 of the cardinal symptoms:tremor, bradykinesia, rigidity)
- Mini Mental State Examination \> 24
- Anti-parkinsonian medications stable for one month
- Hoehn and Yahr II-IV
- Age 18 and above
Exclusion
- Atypical parkinsonism
- History of seizure, drug addiction
- Use of typical neuroleptics
- Previous use of glutathione
Key Trial Info
Start Date :
September 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2007
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01177319
Start Date
September 1 2003
End Date
March 1 2007
Last Update
August 9 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
USF Parkinson's Disease and Movement Disorders Center
Tampa, Florida, United States, 33606